COMPANION Results Will Better Define Resynch ICD Population – NEJM
This article was originally published in The Gray Sheet
Executive Summary
Congestive heart failure patients that are symptomatic due to ischemic cardiomyopathy and a wide QRS complex may be appropriate candidates for resynchronization therapy combined with a defibrillator, an editorial appearing in the June 13 New England Journal of Medicine suggests
You may also be interested in...
Guidant Solution To Panel Dilemma Will Not Require New Contak Implants
Guidant's Contak CD "continued access policy" IDE could augment the company's pivotal trial and allow the firm to avoid returning for a second review by the Circulatory System Devices Panel.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.